Clinical Publications 2021
 
  1. Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohorts. Sherman BT, Hu X, Singh K, Haine L, Rupert AW, Neaton JD, Lundgren JD, Imamichi T, Chang W, Lane HC; ESPRIT, SMART and START Study Groups.
    AIDS. 2021;35(2):193-204. Abstract
     
  2. How are rapid diagnostic tests for infectious diseases used in clinical practice: a global survey by the International Society of Antimicrobial Chemotherapy (ISAC). Poole S, Townsend J, Wertheim H, Kidd SP, Welte T, Schuetz P, Luyt CE, Beishuizen A, Jensen JS, Del Castillo JG, Plebani M, Saeed K.
    Eur J Clin Microbiol Infect Dis. 2021;40(2):429-434. Abstract
     
  3. Identification of two different coagulation phenotypes in people living with HIV with undetectable viral replication. Fink A, Knudsen AD, Thudium RF, Von Stemann JH, Afzal S, Lundgren J, Kirkegaard-Klitbo DM, Ostrowski SR, Nordestgaard BG, Nielsen SD.
    Sci Rep. 2021;11(1):4383. Abstract
     
  4. Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents. Byonanebye DM; RESPOND Study Group.
    AIDS. 2021.Epub ahead of print. Abstract
     
  5. Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients. Rezahosseini O, Ekenberg C, Møller DL, Sørensen SS, Wareham NE, Perch M, Gustafsson F, Rasmussen A, Kirkby N, Reekie J, Lundgren J, Nielsen SD.
    J Infect Dis. 2021:jiab024. Abstract
     
  6. Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International Laboratory. Podlekareva DN, Folkvardsen DB, Skrahina A, Vassilenko A, Skrahin A, Hurevich H, Klimuk D, Karpov I, Lundgren JD, Kirk O, Lillebaek T.
    Tuberc Res Treat. 2021;2021:6646239. Abstract
     
  7. Causes and outcomes of hospitalizations among people living with HIV in Georgia's referral institution, 2012-2017. Rukhadze N, Kirk O, Chkhartishvili N, Bolokadze N, Sharvadze L, Gabunia P, Lundgren J, Tsertsvadze T.
    Int J STD AIDS. 2021:956462420984701. Abstract
     
  8. Prevalence and Outcomes for Heavily Treatment-Experienced (HTE) Individuals Living with Human Immunodeficiency Virus in a European Cohort. Pelchen-Matthews A, Borges ÁH, Reekie J, Rasmussen LD, Wiese L, Weber J, Pradier C, Degen O, Paredes R, Tau L, Flamholc L, Gottfredsson M, Kowalska J, Jablonowska E, Mozer-Lisewska I, Radoi R, Vasylyev M, Kuznetsova A, Begovac J, Svedhem V, Clark A, Cozzi-Lepri A; EuroSIDA study
    J Acquir Immune Defic Syndr. 2021. Epub ahead of print. Abstract
     
  9. Hematological toxicity in patients with solid malignant tumors treated with radiation - Temporal analysis, dose response and impact on survival. Terrones-Campos C, Ledergerber B, Vogelius IR, Helleberg M, Specht L, Lundgren J.
    Radiother Oncol. 2021;158:175-183. Abstract
     
  10. Pulmonary Arterial Enlargement in Well-Treated Persons With Human Immunodeficiency Virus. Knudsen AD, Ronit A, Kristensen T, Thomsen MT, Lebech AM, Cuong MH, Sigvardsen PE, Kühl JT, Fuchs A, Køber L, Lundgren J, Vestbo J, Kofoed KF, Nielsen SD.
    J Infect Dis. 2021;223(1):94-100. Abstract
     
  11. The association of human leukocyte antigen alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies. Ekenberg C, Reekie J, Zucco AG, Murray DD, Sharma S, Macpherson CR, Babiker A, Kan V, Lane HC, Neaton JD, Lundgren JD; INSIGHT START, SMART Study Groups.
    AIDS. 2021;35(5):783-789. Abstract
     
  12. Collaborative tuberculosis/HIV activities in the European Region. de Vries G, van de Berg S, van Dam A, Hasanova S, Pareek M, van der Werf MJ, Podlekareva DN.
    ERJ Open Res. 2021;7(1):00721-2020. Abstract
     
  13. Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States. Boettiger DC, Newall AT, Phillips A, Bendavid E, Law MG, Ryom L, Reiss P, Mocroft A, Bonnet F, Weber R, El-Sadr W, d'Arminio Monforte A, de Wit S, Pradier C, Hatleberg CI, Lundgren J, Sabin C, Kahn JG, Kazi DS.
    J Int AIDS Soc. 2021;24(3):e25690. Abstract
     
  14. Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study. Baxter JD, Dunn D, Tostevin A, Marvig RL, Bennedbaek M, Cozzi-Lepri A, Sharma S, Kozal MJ, Gompels M, Pinto AN, Lundgren J; INSIGHT START Study Group.
    HIV Med. 2021;22(5):360-371. Abstract
     
  15. ABO blood types and sepsis mortality. Itenov TS, Sessler DI, Khanna AK, Ostrowski SR, Johansson PI, Erikstrup C, Pedersen OB, Rygård SL, Holst LB, Bestle MH, Hein L, Lindhardt A, Tousi H, Andersen MH, Mohr T, Lundgren JD, Jensen JU.
    Ann Intensive Care. 2021;11(1):61. Abstract
     
  16. Human immunotypes impose selection on viral genotypes through viral epitope specificity. Gabrielaite M, Bennedbæk M, Zucco AG, Ekenberg C, Murray DD, Kan VL, Touloumi G, Vandekerckhove L, Turner D, Neaton J, Lane HC, Safo S, Arenas-Pinto A, Polizzotto MN, Günthard HF, Lundgren JD, Marvig RL; INSIGHT START trial group.
    J Infect Dis. 2021:jiab253. Epub ahead of print. Abstract
     
  17. Prevalence and outcomes of pregnancies in women living with HIV over a 20-year period: The EuroSIDA study, 1996 to 2015. Kowalska JD, Pelchen-Matthews A, Ryom L, Losso MH, Trofimova T, Mitsura VM, Khromova I, Paduta D, Stephan C, Domingo P, Bakowska E, Monforte AD, Oestergaard L, Jablonowska E, Kuznetsova A, Moreno S, Vasylyev M, Pradier C, Battegay M, Vandekerckhove L, Castagna A, Raben D, Mocroft A; EuroSIDA Study Group.
    AIDS. 2021.Epub ahead of print. Abstract
     
  18. Bacterial and fungal bloodstream infections in solid organ transplant recipients: result from a Danish cohort with nationwide follow-up. Clin Microbiol Infect. Møller DL, Sørensen SS, Perch M, Gustafsson F, Rezahosseini O, Knudsen AD, Scheike T, Knudsen JD, Lundgren J, Rasmussen A, Nielsen SD.
    Clin Microbiol Infect. 2021 :S1198-743X(21)00413-4. Epub ahead of print. Abstract
     
  19. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL. Atkinson A, Miro JM, Mocroft A, Reiss P, Kirk O, Morlat P, Ghosn J, Stephan C, Mussini C, Antoniadou A, Doerholt K, Girardi E, De Wit S, Kraus D, Zwahlen M, Furrer H; Opportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD.
    J Int AIDS Soc. 2021 Jun;24(6):e25726. Abstract
     
  20. Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next steps. Kraef C, Bentzon A, Skrahina A, Mocroft A, Peters L, Lundgren JD, Chkhartishvili N, Podlekareva D, Kirk O. 
    HIV Med. 2021 Sep 1. Online ahead of print. Abstract
     
  21. Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next Generation Sequencing. Lodding IP, Jørgensen M, Bennedbæk M, Kirkby N, Naegele K, Gustafsson F, Perch M, Rasmussen A, Sengeløv H, Sørensen SS, Hirsch HH, Lundgren JD 
    Open Forum Infectious Diseases, 2021; ofab462. Abstract
     
  22. Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort study. Kraef C, Bentzon A, Panteleev A, Skrahina A, Bolokadze N, Tetradov S, Podlasin R, Karpov I, Borodulina E, Denisova E, Azina I, Lundgren J, Johansen IS, Mocroft A, Podlekareva D, Kirk O; T. B.:H. I. V. Study Group.
    BMC Infect Dis. 2021 Oct 6;21(1):1038. Abstract
     
  23. Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). Murray DD, Babiker AG, Baker JV, Barkauskas CE, Brown SM, Chang CC, Davey VJ, Gelijns AC, Ginde AA, Grund B, Higgs E, Hudson F, Kan VL, Lane HC, Murray TA, Paredes R, Parmar MK, Pett S, Phillips AN, Polizzotto MN, Reilly C, Sandkovsky U, Sharma S, Teitelbaum M, Thompson BT, Young BE, Neaton JD, Lundgren JD.
    Clin Trials. 2021 Oct 10:17407745211049829. Epub ahead of print. Abstract
     
  24. The central role of the glutamate metabolism in long-term antiretroviral treated HIV-infected individuals with metabolic syndrome. Gelpi M, Mikaeloff F, Knudsen AD, Benfeitas R, Krishnan S, Svenssson Akusjärvi S, Høgh J, Murray DD, Ullum H, Neogi U, Nielsen SD.
    Aging (Albany NY). 2021 Oct 11;13(19):22732-22751. Abstract
     
  25. The hepatitis C cascade of care in HIV/HCV-coinfected individuals in Europe- regional and intra-regional differences. Fursa O, Mocroft A, Lazarus JV, Amele S, Lundgren J, Matulionyte R, Rasmussen LD, Rockstroh JK, Parczewski M, Jilich D, Moreno S, Vassilenko A, Lacombe K, Wandeler G, Borodulina E, Brännström J, Wiese L, Orkin C, Behrens GMN, Mansinho K, Portu JJ, Peters L; EuroSIDA study.
    AIDS. 2021 Oct 25. doi: 10.1097/QAD.0000000000003112. Epub ahead of print. Abstract
     
  26. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium. Bansi-Matharu L, Phillips A, Oprea C, Grabmeier-Pfistershammer K, Günthard HF, De Wit S, Guaraldi G, Vehreschild JJ, Wit F, Law M, Wasmuth JC, Chkhartishvili N, d'Arminio Monforte A, Fontas E, Vesterbacka J, Miro JM, Castagna A, Stephan C, Llibre JM, Neesgaard B, Greenberg L, Smith C, Kirk O, Duvivier C, Dragovic G, Lundgren J, Dedes N, Knudsen A, Gallant J, Vannappagari V, Peters L, Elbirt D, Sarcletti M, Braun DL, Necsoi C, Mussini C, Muccini C, Bolokadze N, Hoy J, Mocroft A, Ryom L.
    Lancet HIV. 2021:S2352-3018(21)00163-6. Epub ahead of print. Abstract
     
  27. Patient perspectives on integrated healthcare for HIV, hypertension and type 2 diabetes: a scoping review. Singh S, Kirk O, Jaffar S, Karakezi C, Ramaiya K, Kallestrup P, Kraef C.
    BMJ Open. 2021;11(11):e054629. Abstract
     
  28. Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap. Crone CG, Helweg-Larsen J, Steensen M, Arendrup MC, Helleberg M.
    J Mycol Med. 2021;32(1):101228. Abstract
     
  29. An Observational Prospective Cohort Study of Incidence and Outcome of Streptococcus pneumoniae and Hemophilus influenzae Infections in Adult Solid Organ Transplant Recipients. Rezahosseini O, Møller DL, Sørensen SS, Perch M, Gustafsson F, Gelpi M, Knudsen J, Helleberg M, Rasmussen A, Nielsen SD, Harboe ZB.
    Microorganisms. 2021;9(7):1371. Abstract
     
  30. Hypersensitivity reactions, hepatotoxicity and other discontinuations in persons receiving integrase strand transfer inhibitors: Results from the EuroSIDA study. Pelchen-Matthews A, Larsen JF, Shepherd L, Begovac J, Pedersen K, De Wit S, Horban A, Jablonowska E, Johnson M, Khromova I, Losso MH, Nielsen LN, Ridolfo AL, Schmied B, Stephan C, Yust I, Curtis L, Vannappagari V, Ragone L, Roen A, Raben D, Kirk O, Peters L, Mocroft A; EuroSIDA Study Group.
    HIV Res Clin Pract. 2021;22(6):160-168. Abstract
     
  31. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. Mocroft A, Miro JM, Wandeler G, Llibre JM, Boyd A, van Bremen K, Beniowski M, Mikhalik J, Cavassini M, Maltez F, Duvivier C, Uberti Foppa C, Knysz B, Bakowska E, Kuzovatova E, Domingo P, Zagalo A, Viard JP, Degen O, Milinkovic A, Benfield T, Peters L; EuroSIDA study group.
    HIV Med. 2021. Epub ahead of print.Abstract
     
  32. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe. Amele S, Sandri AK, Rodger A, Vandekerckhove L, Benfield T, Milinkovic A, Duvivier C, Stellbrink HJ, Sambatakou H, Chkhartishvili N, Caldeira L, Laguno M, Domingo P, Wandeler G, Gisinger M, Kuzovatova E, Dragovic G, Knysz B, Matulionyte R, Rockstroh JK, Lundgren JD, Mocroft A, Peters L; EuroSIDA study group.
    HIV Med. 2021. Epub ahead of print. Abstract
     
  33. Vaccination against herpes zoster. Larsen CS, Helleberg M.
    Ugeskr Laeger. 2021;183(47):V07210585. Abstract
     
  34. Invasive aspergillosis in patients with severe COVID-19 pneumonia.  Helleberg M, Steensen M, Arendrup MC.
    Clin Microbiol Infect. 2021;27(1):147-148. Abstract
     
  35. Response to Aviv et al. Helleberg M, Niemann CU, Moestrup KS, Kirk O, Lebech AM, Lundgren J.
    J Infect Dis. 2021;224(3):559-561. Abstract
     
  36. Genetic Variants and Immune Responses in a Cohort of Patients With Varicella Zoster Virus Encephalitis. Thomsen MM, Tyrberg T, Skaalum K, Carter-Timofte M, Freytag MR, Norberg P, Helleberg M, Storgaard M, Nielsen H, Bodilsen J, Grahn A, Mogensen TH.
    J Infect Dis. 2021;224(12):2122-2132. Abstract
     
  37. Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole. Risum M, Vestergaard MB, Weinreich UM, Helleberg M, Vissing NH, Jørgensen R.
    Antibiotics (Basel). 2021;10(5):487. Abstract
     
  38. At-Risk Groups of Men Who Have Sex With Men can be Reached Through Community-Based HIV Testing in Denmark. Munck HN, Qvist T, Helleberg M, Kaye PS, Pichon F, Cowan S.
    AIDS Educ Prev. 2021;33(5):439-449. Abstract
     
  39. Human subcutaneous dirofilariasis: the 'migrating' skin tumor. Mistry MA, Hoejvig J, Helleberg M, Stensvold CR, Jokelainen P, Noehr A, Bonde C.
    UCase Reports Plast Surg Hand Surg. 2021;8(1):181-185. Abstract
     
  40. Dissection of the Activity of Agricultural Fungicides against Clinical Aspergillus Isolates with and without Environmentally and Medically Induced Azole Resistance. Jørgensen KM, Helleberg M, Hare RK, Jørgensen LN, Arendrup MC.
    J Fungi (Basel). 2021;7(3):205. Abstract
     
  41. Postpartum Disseminated Herpes Simplex Virus Type 1 Infection With Hemophagocytic Lymphohistiocytosis and Fulminant Neonatal Herpes Infection. Freytag MR, Jørgensen SE, Thomsen MM, Al-Mousawi A, Hait AS, Olagnier D, Bay JT, Helleberg M, Mogensen TH.
    J Infect Dis. 2022;225(1):157-162. Abstract
     
  42. Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study. Benfield T, Bodilsen J, Brieghel C, Harboe ZB, Helleberg M, Holm C, Israelsen SB, Jensen J, Jensen TØ, Johansen IS, Johnsen S, Lindegaard B, Lundgren J, Meyer CN, Mohey R, Pedersen LM, Nielsen H, Nielsen SL, Obel N, Omland LH, Podlekareva D, Poulsen BK, Ravn P, Sandholdt H, Starling J, Storgaard M, Søborg C, Søgaard OS, Tranborg T, Wiese L, Christensen HR.
    Clin Infect Dis. 2021;73(11):2031-2036. Abstract
     

IN PRESS